Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ONWARD Medical NV

< Previous 1 2 Next >
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Publishes Annual Sustainability Summary
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
From ONWARD Medical NV
Via GlobeNewswire
Tickers RWAY
ONWARD® Medical Announces Participation in Stifel European Healthcare Summit
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication
From ONWARD Medical NV
Via GlobeNewswire
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
From ONWARD Medical NV
Via GlobeNewswire
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Publishes Prospectus for Listing of New Shares
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookbuild Offering and by Way of a Public Offering in France
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Public Offering in France for an Indicative Amount of EUR 15 Million, with an Up to EUR 5 Million Upsize Option
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Successfully Completes Benchmark Testing on Path to Commercialize ARC-EX® System
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System
From ONWARD Medical NV
Via GlobeNewswire
ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA
From ONWARD Medical NV
Via GlobeNewswire
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
From ONWARD Medical NV
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.